BIOIF Biome Grow Inc

USD 0.01 0.00 0
Icon

Biome Grow Inc (BIOIF) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.008999999999999999

0.00 (0.00)%

USD 0.68M

N/A

N/A

N/A

Icon

BIOIF

Biome Grow Inc (USD)
COMMON STOCK | OTC
USD 0.01
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.68M

N/A

USD 0.01

Biome Grow Inc (BIOIF) Stock Forecast

N/A

Based on the Biome Grow Inc stock forecast from 0 analysts, the average analyst target price for Biome Grow Inc is not available over the next 12 months. Biome Grow Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biome Grow Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Biome Grow Inc’s stock price was USD 0.008999999999999999. Biome Grow Inc’s stock price has changed by +0.00% over the past week, +100.00% over the past month and +28.57% over the last year.

No recent analyst target price found for Biome Grow Inc
No recent average analyst rating found for Biome Grow Inc

Company Overview Biome Grow Inc

Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.

https://www.biomegrow.com

480 University Avenue, Toronto, ON, Canada, M5G 1V2

0

December

USD

USA

Adjusted Closing Price for Biome Grow Inc (BIOIF)

Loading...

Unadjusted Closing Price for Biome Grow Inc (BIOIF)

Loading...

Share Trading Volume for Biome Grow Inc Shares

Loading...

Compare Performance of Biome Grow Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOIF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biome Grow Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MKKGY
Merck KGaA ADR 0.00 (0.00%) USD79.59B 26.15 14.08

ETFs Containing BIOIF

Symbol Name BIOIF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biome Grow Inc (BIOIF) Stock

Stock Target Advisor's fundamental analysis for Biome Grow Inc's stock is Bearish.

Unfortunately we do not have enough data on BIOIF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIOIF's stock to indicate what its average analyst target is.

BIOIF stock's Price/Earning ratio is 0.60. Our analysis grades BIOIF stock's Price / Earning ratio at B-. This means that BIOIF stock's Price/Earning ratio is above 18% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this BIOIF may be undervalued for its sector.

The last closing price of BIOIF's stock was USD 0.01.

The most recent market capitalization for BIOIF is USD 0.68M.

Unfortunately we do not have enough analyst data on BIOIF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biome Grow Inc's stock.

As per our most recent records Biome Grow Inc has 0 Employees.

Biome Grow Inc's registered address is 480 University Avenue, Toronto, ON, Canada, M5G 1V2. You can get more information about it from Biome Grow Inc's website at https://www.biomegrow.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...